Assembly Biosciences Inc (NASDAQ:ASMB) Director William R. Ringo sold 1,000 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $46.86, for a total transaction of $46,860.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Shares of Assembly Biosciences Inc (ASMB) opened at $46.57 on Monday. Assembly Biosciences Inc has a one year low of $18.60 and a one year high of $52.37.
ASMB has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded shares of Assembly Biosciences from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a research report on Wednesday, November 15th. Jefferies Group initiated coverage on shares of Assembly Biosciences in a research report on Wednesday, November 8th. They issued a “buy” rating and a $50.00 price target on the stock. BidaskClub downgraded shares of Assembly Biosciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, December 6th. ValuEngine downgraded shares of Assembly Biosciences from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. Finally, B. Riley initiated coverage on shares of Assembly Biosciences in a research report on Friday, January 5th. They issued a “neutral” rating and a $35.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $39.25.
COPYRIGHT VIOLATION NOTICE: “Insider Selling: Assembly Biosciences Inc (ASMB) Director Sells 1,000 Shares of Stock” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.com-unik.info/2018/02/05/insider-selling-assembly-biosciences-inc-asmb-director-sells-1000-shares-of-stock.html.
About Assembly Biosciences
Assembly Biosciences, Inc is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome.
Receive News & Ratings for Assembly Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assembly Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.